# EDGAR Filing Document

**Accession Number:** 0000720154
**File Stem:** 0001062993-23-002090
**Filing Date:** 2023-2
**Character Count:** 7062
**Document Hash:** 8c31f71fde1de4574b086475cd9c268b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-002090.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001062993-23-002090

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230124

**FILED AS OF DATE**: 20230203

**DATE AS OF CHANGE**: 20230203

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Landman David
- **CENTRAL INDEX KEY:** 0001964248

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-23357
- **FILM NUMBER:** 23585674

**MAIL ADDRESS:**
- **STREET 1:** 2701 KENT AVENUE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Inotiv, Inc.
- **CENTRAL INDEX KEY:** 0000720154
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **IRS NUMBER:** 351345024
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 2701 KENT AVE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382
- **BUSINESS PHONE:** 3174634527

**MAIL ADDRESS:**
- **STREET 1:** 2701 KENT AVENUE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIOANALYTICAL SYSTEMS INC
- **DATE OF NAME CHANGE:** 19970918

## Ex-24

```

POWER OF ATTORNEY

For Executing Forms 3, 4, 5 and 144

       The undersigned hereby constitutes and
Appoints each of Nicole McDaniel, Beth Taylor,
and Fernanda Beraldi, signing singly, as
the undersigned's true and lawful attorney-in
-fact, for such period of time that the
Undersigned is required to file reports
pursuant to Section 16(a) of the Securities
Exchange Act of 1934,as amended (the
"Exchange Act"), or Rule 144 of the
Securities Act of 1933, as amended
the "Securities Act"), due to his
affiliation with Inotiv, Inc., an
Indiana corporation, unless earlier
revoked by the undersigned in
a signed writing delivered to the
foregoing attorneys-in-fact, to:

1) execute for and on behalf of the
undersigned Form ID, Forms 3, 4, 5 and
144 and any amendments to previously
filed forms in accordance with Section
16(a) of the Exchange Act or Rule 144
of the Securities Act and the rules
thereunder;

2) do and perform any and all acts for and
on behalf of the undersigned which may
be necessary or desirable to complete
the execution of any such Form ID, Forms 3,
4, 5 and 144 and the timely filing of
such form with the United States
Securities and Exchange Commission
and any other authority as required
by law; and

3) take any other action of any type
whatsoever in connection with the
foregoing which, in the opinion of
such attorney-in-fact, may be of
benefit to, in the best interest of
or legally required by the undersigned,
it being understood that the documents
executed by such attorney-in-fact on
behalf of the undersigned pursuant to
this Power of Attorney shall be in such
form and shall contain such terms and
conditions as such attorney-in-fact
may approve in his discretion.

       The undersigned hereby grants to
each such attorney-in-fact full power and
authority to do and perform all and every act
and thing whatsoever requisite, necessary and
proper to be done in the exercise of any of
the rights and powers herein granted, as
fully to all intents and purposes as the
undersigned could do if personally present,
with full power of substitution or revocation,
hereby ratifying and confirming all that
such attorney-in-fact, or his substitute
or substitutes, shall lawfully do or cause to
be done by virtue of this Power of Attorney
and the rights and powers herein granted.
The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving
in such capacity at the request of the
undersigned, are not assuming any of the
undersigned's responsibilities to comply
with Section 16 of the Exchange Act
or Rule 144 of the Securities Act.

        IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to
be executed as of this 26th day of
January, 2023.

/s/ David Landman
David Landman

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Landman David<br><sub>(Last) (First) (Middle)</sub><br>2701 KENT AVENUE<br><sub>(Street)</sub><br>WEST LAFAYETTE, IN 47906-1382<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Inotiv, Inc. [ NOTV ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-24 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 0<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) No securities beneficially owned.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Fernanda Beraldi, Attorney-in-Fact for David Landman  
**Date:** 2023-02-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**